Idelalisib or placebo in combination with bendamustine and rituximab in patients with relapsed or refractory chronic lymphocytic leukaemia: interim results from a phase 3, randomised, double-blind, placebo-controlled trial - Publication - Bridge of Knowledge

Search

Idelalisib or placebo in combination with bendamustine and rituximab in patients with relapsed or refractory chronic lymphocytic leukaemia: interim results from a phase 3, randomised, double-blind, placebo-controlled trial

Abstract

Citations

  • 1 7 4

    CrossRef

  • 1 6 4

    Web of Science

  • 1 7 9

    Scopus

Authors (23)

  • Photo of  Andrew Zelenetz

    Andrew Zelenetz

  • Photo of  Jacqueline Barrientos

    Jacqueline Barrientos

  • Photo of  Jennifer Brown

    Jennifer Brown

  • Photo of  Bertrand Coiffier

    Bertrand Coiffier

  • Photo of  Julio Delgado

    Julio Delgado

  • Photo of  Miklós Egyed

    Miklós Egyed

  • Photo of  Paolo Ghia

    Paolo Ghia

  • Photo of  Árpád Illés

    Árpád Illés

  • Photo of MD, PhD, Prof Wojciech Jurczak

    Wojciech Jurczak MD, PhD, Prof

  • Photo of  Paula Marlton

    Paula Marlton

  • Photo of  Marco Montillo

    Marco Montillo

  • Photo of  Franck Morschhauser

    Franck Morschhauser

  • Photo of  Alexander Pristupa

    Alexander Pristupa

  • Photo of  Tadeusz Robak

    Tadeusz Robak

  • Photo of  Jeff Sharman

    Jeff Sharman

  • Photo of  David Simpson

    David Simpson

  • Photo of  Lukáš Smolej

    Lukáš Smolej

  • Photo of  Eugen Tausch

    Eugen Tausch

  • Photo of  Adeboye Adewoye

    Adeboye Adewoye

  • Photo of  Lyndah Dreiling

    Lyndah Dreiling

  • Photo of  Yeonhee Kim

    Yeonhee Kim

  • Photo of  Stephan Stilgenbauer

    Stephan Stilgenbauer

  • Photo of  Peter Hillmen

    Peter Hillmen

Cite as

Full text

full text is not available in portal

Details

Category:
Magazine publication
Type:
Magazine publication
Published in:
LANCET ONCOLOGY no. 18, edition 3, pages 297 - 311,
ISSN: 1470-2045
ISSN:
1470-2045
Publication year:
2017
DOI:
Digital Object Identifier (open in new tab) 10.1016/s1470-2045(16)30671-4
Verified by:
No verification

seen 34 times

Meta Tags